This page shows the latest Project TWENTY21 news and features for those working in and with pharma, biotech and healthcare.
Called Project TWENTY21, the pilot intends to enrol the 20, 000 subjects by the end of 2021 and take a real-world approach to generating data on the safety, efficacy and ... As a lack of clinical evidence is the main reason for rejecting cases, Project
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
No results were found
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...